With 3.37 million shares changed hands, the volume of the stock remained lighter than its average volume of 20.27 million shares. The 52-week range on HEPA shows that it touched its highest point at $3.33 and its lowest point at $0.12 during that stretch. It currently has a 1-year price target of $22.00. Beta for the stock currently stands at 1.59.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of HEPA was down-trending over the past week, with a drop of -14.98%, but this was down by -19.62% over a month. Three-month performance dropped to -77.93% while six-month performance fell -81.29%. The stock lost -93.75% in the past year, while it has lost -67.41% so far this year.
Float and Shares Shorts:
At present, 10.62 million HEPA shares are outstanding with a float of 10.57 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for HEPA since 1 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$11.43 being high and -$11.43 being low. For HEPA, this leads to a yearly average estimate of -$11.43. Based on analyst estimates, the high estimate for the next quarter is $0 and the low estimate is $0. The average estimate for the next quarter is thus $0.
